Latin‐American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

200372 citationsJournal Article

Authors

Alfredo Halpern · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Márcio C. Mancini · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Henrique Suplicy · Hospital de Clínicas Universidade Federal do Paraná

Maria Teresa Zanella · Associação Paulista de Medicina

Giorgio Repetto · Pontifícia Universidade Católica do Rio Grande do Sul

Jorge Luiz Gross · Hospital de Clínicas de Porto Alegre

Abstract

Orlistat is a useful and an effective therapy in obese diabetic patients, promoting clinically significant weight loss and improved glycaemic control and lipid profile.

Topics & Keywords

Pharmacology and Obesity Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Obesity and Metabolism

Volume 5, Issue 3, pp. 180-188

DOI: 10.1046/j.1463-1326.2003.00262.x

Field-Weighted Citation Impact: 5.85